Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

hypotonic

PreclinicalSmall molecule

HHospital Civil de Guadalajara

1

Indications

2

Total Trials

0

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

HypernatremiaActive, not recruiting

HypernatremiaPreclinical

Active, not recruiting

Clinical

Trials by Indication[1]

Critically Ill1 trial

0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children

Completed·HHospital General de Niños Pedro de Elizalde·N/A·NCT01301274·66 enrolled

Hypernatremia1 trial

Correction of Hypernatremia by Intravenous Hypotonic Solution Compared to Enteral Water

Unknown status·HHospital Civil de Guadalajara·N/A·NCT06061783·178 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for hypotonic. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — hypotonic compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for hypotonic. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hospital Civil de Guadalajara company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: HHospital Civil de Guadalajara

Related News